Root canal treatment reduces heart disease and diabetes risk, study finds

A new clinical study suggests that fixing an infected tooth with a successful root canal may do more than stop pain — it could also ease inflammation and improve markers tied to heart disease and diabetes. Researchers tracked patients’ blood chemistry for two years after treatment and say the results reveal measurable benefits beyond the mouth.

The study, led by scientists at King’s College London and published in the Journal of Translational Medicine, followed adults treated for apical periodontitis, a common dental infection. By analyzing changes in glucose, fats and inflammation markers, the team reports improvements that could translate into lower cardiometabolic risk for patients whose dental infections are resolved.

Root canal treatment tied to improved blood sugar and cholesterol measures

Following root canal therapy, patients showed biochemical changes that point toward improved metabolic and cardiovascular health. Over the 24-month follow-up, investigators detected a notable decline in blood glucose and short-term improvements in lipid measures that are closely tied to heart disease risk.

• Blood sugar: Glucose levels dropped significantly during the two years after treatment, a key factor in reducing the risk of developing diabetes.
• Lipid profile: Cholesterol and fatty acid markers showed favorable shifts in the months after treatment, indicating temporary improvements in cardiovascular risk factors.
• Inflammation: Several inflammatory biomarkers that are associated with heart disease decreased over time following successful therapy.

How the researchers tracked body-wide effects of a dental infection

Instead of relying solely on standard dental outcomes, the team measured a wide panel of molecules in the bloodstream to see how the body’s metabolism responded before and after treatment. They used nuclear magnetic resonance (NMR) spectroscopy — a technique commonly used to profile proteins and metabolites — to get a detailed snapshot of blood chemistry.

What the blood tests revealed

The molecular readout included:

• Glucose and other sugar-processing indicators
• Triglycerides and cholesterol-related lipids
• Amino acids like tryptophan tied to metabolic and immune signaling

Patterns in these markers suggested that untreated root canal infections can nudge systemic metabolism toward a state associated with higher cardiometabolic risk, while successful treatment moves many of those signals in a healthier direction.

The patient sample and clinical design that produced the findings

The study followed 65 patients in England who underwent root canal therapy for apical periodontitis. Blood samples were collected and analyzed over a two-year period after treatment to monitor longitudinal changes in metabolism and inflammation.

• Sample size: 65 patients
• Follow-up duration: 2 years
• Primary focus: changes in blood-based metabolic and inflammatory markers after successful treatment

Why a tooth infection can affect the rest of the body

Dental infections such as apical periodontitis can allow bacteria and bacterial products to enter the bloodstream, triggering immune responses and systemic inflammation. Chronic inflammation is a well-known driver of atherosclerosis and impaired glucose control, so researchers wanted to know whether removing the dental source of infection would reduce that systemic burden.

By resolving the infection, the study found, many of the downstream inflammatory and metabolic signals decreased, consistent with lower long-term risk for conditions like heart disease and type 2 diabetes.

Clinical implications: monitoring, prevention, and integrated care

Lead investigator Dr. Sadia Niazi and colleagues argue that these results emphasize the broader health value of timely dental care. They suggest that monitoring specific blood markers — such as glucose, triglycerides and inflammatory proteins — could help clinicians follow recovery after endodontic treatment and identify patients at lingering risk.

Suggested clinical actions emerging from the research include:

1. Prioritizing early diagnosis and treatment of root canal infections to limit systemic inflammation.
2. Considering blood metabolic markers as part of post-treatment follow-up for higher-risk patients.
3. Encouraging cross-disciplinary communication between dentists and primary care physicians to manage cardiometabolic risk holistically.

Limitations, next steps, and research opportunities

While the data are promising, the study is relatively small and focused on a specific dental condition and treatment. Larger studies across diverse populations will be needed to confirm the findings, map the duration of lipid benefits, and identify which patients gain the most systemic advantage from treatment.

The researchers say the work opens avenues for future trials that combine dental interventions with routine medical monitoring, potentially using NMR-based metabolic profiling to personalize follow-up care.

What patients and clinicians should take away now

For patients, the practical message is straightforward: treating persistent dental infections may have benefits that extend beyond saving a tooth. For dental and medical professionals, the study supports a more integrated approach to patient health — one that recognizes oral infections as potential contributors to systemic disease and uses measurable blood markers to guide recovery and risk reduction.

Dr. Niazi emphasizes that long-standing tooth infections can raise circulating inflammation and metabolic disturbances, and she urges clinicians to pursue early intervention and collaborative care models that track and manage these risks through both dental treatment and regular medical monitoring.

You might also like:

• Amino acid identified as key to survival in severe illness, study shows
• Art gallery visits linked to lower heart disease risk, study finds
• Tooth implanted in 34-year-old’s eye restores vision after 20 years
• Cancer breath test hailed as most significant step toward lifesaving breakthrough in 50 years
• Cancer-fighting cells engineered in patients’ bodies for the first time

Michael Thompson

Michael Thompson is an experienced journalist covering U.S. and global news. With ten years on the front lines, he breaks down political and economic stories that matter. His precise writing and keen attention to detail help you grasp the real‑world impact of every event.